Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677
Eva Maria Ratai, Zheng Zhang, Bradley S. Snyder, Jerrold L. Boxerman, Yair Safriel, Robert C. McKinstry, Felix Bokstein, Mark R. Gilbert, A. Gregory Sorensen, Daniel P. Barboriak
Dive into the research topics of 'Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677'. Together they form a unique fingerprint.